Conflicting instructions Just got my first ever order of tesamorelin from Amble. On the app, doctor’s instructions are to Inject 13 units under the skin at bedtime, 5 days per week, for 4 weeks. But on the pill bottle, instructions say 13 units once a week. Amble is notoriously slow at responding to questions through its message system. Anyone with some insight as to which instructions to follow?

References

1. Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy.Linda M Spooner, Jacqueline L OlinThe Annals of pharmacotherapy • Feb 2012 • PMID: 22298602
2. Epidemiology and management of antiretroviral-associated cardiovascular disease.Daniel B Chastain, Harold Henderson, Kayla R StoverThe open AIDS journal • 2015 • PMID: 25866592
3. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.Julian Falutz, Jean-Claude Mamputu, Diane Potvin, Graeme Moyle, Graziella Soulban, Helen Loughrey et al.The Journal of clinical endocrinology and metabolism • Sep 2010 • PMID: 20554713
4. Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.Takara L Stanley, Julian Falutz, Jean-Claude Mamputu, Graziella Soulban, Diane Potvin, Steven K GrinspoonAIDS (London, England) • Jun 2011 • PMID: 21516030
5. Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy.Roger BedimoHIV/AIDS (Auckland, N.Z.) • 2011 • PMID: 22096409
6. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.Takara L Stanley, Meghan N Feldpausch, Jinhee Oh, Karen L Branch, Hang Lee, Martin Torriani et al.JAMA • • PMID: 25038357
7. Tesamorelin: A hope for ART-induced lipodystrophy.Akash Patel, Hardik Gandhi, Aman UpaganlawarJournal of pharmacy & bioallied sciences • Apr 2011 • PMID: 21687371
8. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.Takara L Stanley, Steven K GrinspoonGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society • Apr 2015 • PMID: 25555516
9. Pathogenesis and treatment of HIV lipohypertrophy.Vivien L Leung, Marshall J GlesbyCurrent opinion in infectious diseases • Feb 2011 • PMID: 21124215
10. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.Julian Falutz, Diane Potvin, Jean-Claude Mamputu, Hani Assaad, Monika Zoltowska, Sophie-Elise Michaud et al.Journal of acquired immune deficiency syndromes (1999) • Mar 2010 • PMID: 20101189
11. Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.Julian Falutz, Soraya Allas, Jean-Claude Mamputu, Diane Potvin, Donald Kotler, Michael Somero et al.AIDS (London, England) • Sep 2008 • PMID: 18690162
12. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.David R Clemmons, Sam Miller, Jean-Claude MamputuPloS one • 2017 • PMID: 28617838
13. Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.Othman Al MusaimiBiomolecules • Feb 2024 • PMID: 38540684
14. Management of the metabolic effects of HIV and HIV drugs.Todd T Brown, Marshall J GlesbyNature reviews. Endocrinology • Sep 2011 • PMID: 21931374
15. Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers.Shirley Teng, Diane Potvin, Jean-Claude Mamputu, Geneviève Vincent, Monika Zoltowska, Josée Morin et al.Clinical pharmacology in drug development • Jul 2013 • PMID: 27121785
16. Discovery, Optimization, and Clinical Application of Natural Antimicrobial Peptides.Armando A Rodríguez, Anselmo Otero-González, Maretchia Ghattas, Ludger StändkerBiomedicines • Oct 2021 • PMID: 34680498